RITUXIMAB FOR IGG4-RELATED DISEASE: THE NEWCASTLE EXPERIENCE

被引：0
|
作者：
Rayner, Fiona [1 ]
Griffiths, Bridget [1 ]
Nayar, Manu [2 ]
Oppong, Kofi [2 ]
Vila, Josephine [1 ]
机构：
[1] Freeman Rd Hosp, Rheumatol Dept, Newcastle Upon Tyne, Tyne & Wear, England
[2] Freeman Rd Hosp, Gastroenterol Dept, Newcastle Upon Tyne, Tyne & Wear, England
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P117
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
    Wallwork, Rachel
    Wallace, Zachary
    Perugino, Cory
    Sharma, Amita
    Stone, John H.
    MEDICINE, 2018, 97 (42)
  • [42] Rituximab for Idiopathic and IgG4-Related Retroperitoneal Fibrosis
    Wallwork, Rachel
    Wallace, Zachary S.
    Perugino, Cory A.
    Sharma, Amita
    Stone, John H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] Rituximab Monotherapy is Effective for Treatment of Pancreaticobiliary Involvement in IgG4-Related Disease
    Hart, Phil
    Witzig, Thomas
    Topazian, Mark
    Klebig, Robin
    Clain, Jonathan E.
    Gleeson, Ferga C.
    Levy, Michael J.
    Pearson, Randall K.
    Smyrk, Thomas C.
    Petersen, Bret T.
    Takahashi, Naoki
    Vege, Santhi Swaroop
    Chari, Suresh T.
    GASTROENTEROLOGY, 2012, 142 (05) : S458 - S459
  • [44] The Use of Rituximab for IgG4-Related Sclerosing Mesenteritis
    Tome, June
    Kamboj, Amrit K.
    Pardi, Darrell S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1470 - S1470
  • [45] Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis
    Della-Torre, Emanuel
    Campochiaro, Corrado
    Cassione, Emanuele Bozzalla
    Albano, Luigi
    Gerevini, Simonetta
    Bianchi-Marzoli, Stefania
    Bozzolo, Enrica
    Passerini, Gabriella
    Lanzillotta, Marco
    Terreni, Mariarosa
    Callea, Marcella
    Trimarchi, Matteo
    Mortini, Pietro
    Tresoldi, Moreno
    Acerno, Stefania
    Dagna, Lorenzo
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (04): : 441 - 444
  • [46] Rituximab for IgG4-related disease: a prospective, open-label trial
    Carruthers, Mollie N.
    Topazian, Mark D.
    Khosroshahi, Arezou
    Witzig, Thomas E.
    Wallace, Zachary S.
    Hart, Philip A.
    Deshpande, Vikram
    Smyrk, Thomas C.
    Chari, Suresh
    Stone, John H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1171 - 1177
  • [47] Pulmonary IgG4-related disease with favourable response to rituximab: A case report
    Muller, Romain
    Ebbo, Mikael
    Habert, Paul
    Torrents, Julia
    Gaubert, Jean Yves
    Schleinitz, Nicolas
    RESPIROLOGY CASE REPORTS, 2022, 10 (12):
  • [48] Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al
    Stone, John H.
    Carruthers, Mollie N.
    Topazian, Mark D.
    Khosroshahi, Arezou
    Witzig, Thomas E.
    Wallace, Zachary S.
    Hart, Phillip A.
    Deshpande, Vikram
    Smyrk, Thomas C.
    Chari, Suresh
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (08)
  • [49] RITUXIMAB AS THIRD LINE THERAPY IN IGG4-RELATED DISEASE: EXPERIENCE FROM A MULTI-CENTRE COHORT
    Manganis, Charis D.
    Lee, Chen X.
    Peters, Rory J. R.
    David, Joel
    Luqmani, Raashid
    Savic, Sinisa
    Spiller, William
    McCarthy, Eoghan
    Huggett, Matthew
    Geraghty, Joe
    Nayar, Manu
    Vila, Josie
    Culver, Emma L.
    GUT, 2021, 70 : A45 - A45
  • [50] Lung-limited IgG4-related disease: A new form of IgG4-related disease?
    Waseda, Yuko
    Matsui, Shoko
    Yamamoto, Hiroshi
    Ogura, Takashi
    Hebisawa, Akira
    Sakai, Fumikazu
    Terasaki, Yasuhiro
    Kurihara, Yasuyuki
    Chida, Kingo
    Yatagai, Yohei
    Fukushima, Fumiya
    Kuba, Mutsuo
    Miyashita, Koichi
    Toyoshima, Mikio
    Ishida, Masayuki
    Hayashi, Hiroki
    Tsuchiya, Yutaka
    Ohishi, Keishi
    Morio, Yoshiaki
    Konishi, Kenji
    Fujimura, Masaki
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345